Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis

Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

(2022) Chiara Farroni et al.   Frontiers in Immunology

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients

(2021) Uriel Trahtemberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

(2021) Rebecca H Haberman et al.   ANNALS OF THE RHEUMATIC DISEASES

New-onset IgG autoantibodies in hospitalized patients with COVID-19

(2021) Sarah Esther Chang et al.   Nature Communications

Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS‐CoV‐2 Messenger RNA Vaccination

(2021) Caoilfhionn M. Connolly et al.   Arthritis & Rheumatology

Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19

(2021) Claudia Gomes et al.   Life Science Alliance

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

(2020) Rebecca Haberman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anti‐cardiolipin IgG autoantibodies are an independent risk factor of COVID‐19 severity

(2020) Daniel Bertin et al.   Arthritis & Rheumatology

COVID‐19 and immunological dysregulation: can autoantibodies be useful?

(2020) Simona Pascolini et al.   CTS-Clinical and Translational Science

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

(2020) Maria Orietta Borghi et al.   Frontiers in Immunology

COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases

(2020) Mariam Ahmed Saad et al.   Current Rheumatology Reviews

Divergent Roles of Antiself Antibodies during Infection

(2018) Juan Rivera-Correa et al.   TRENDS IN IMMUNOLOGY